Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis

Early diagnosis of spondyloarthritis (SpA) is essential as anti-tumor necrosis factor therapy can achieve significant symptomatic relief and control of disease activity. This study aims to compare the clinical characteristics, disease activity, and functional status of a Chinese cohort of SpA patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Ho Yin, Lau, Chak Sing, Wu, Ka Pik, Wong, Woon Sing, MOK, Mo Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123457/
https://www.ncbi.nlm.nih.gov/pubmed/21336823
http://dx.doi.org/10.1007/s10067-011-1693-6
_version_ 1782206981848694784
author Chung, Ho Yin
Lau, Chak Sing
Wu, Ka Pik
Wong, Woon Sing
MOK, Mo Yin
author_facet Chung, Ho Yin
Lau, Chak Sing
Wu, Ka Pik
Wong, Woon Sing
MOK, Mo Yin
author_sort Chung, Ho Yin
collection PubMed
description Early diagnosis of spondyloarthritis (SpA) is essential as anti-tumor necrosis factor therapy can achieve significant symptomatic relief and control of disease activity. This study aims to compare the clinical characteristics, disease activity, and functional status of a Chinese cohort of SpA patients who were re-classified into ankylosing spondylitis (AS) patients fulfilling the modified New York (MNY) criteria, those with undifferentiated SpA (USpA) fulfilling the European Spondyloarthropathy Study Group (ESSG) classification criteria only (USpA/ESSG) and those who fulfill Assessment of SpondyloArthritis International Society (ASAS) only (USpA/ASAS). Disease activity was evaluated by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), severity of morning stiffness, patient global assessment, and C-reactive protein. Functional status was evaluated by Bath Ankylosing Spondylitis Functional Index (BASFI), modified Schober index, and dimension of chest expansion. One hundred and twenty-eight patients with disease duration of 16.3 ± 10.4 years were recruited. Patients in USpA/ESSG and USpA/ASAS were significantly younger (p = 0.01), had shorter disease duration (p < 0.01), and lower BASFI (p = 0.03) than established AS patients. All three groups have active disease with comparable BASDAI >3. BASFI correlated inversely with dimension of chest expansion and negatively modified Schober index in AS patients (p < 0.01) and modestly with BASDAI (r = 0.25, p < 0.01). BASFI correlated moderately with BASDAI in USpA/ESSG (r = 0.61, p < 0.01) but not with chest expansion or modified Schober index. Compared with established AS patients recognized by MNY criteria, patients fulfilling USpA defined by ESSG or ASAS criteria had earlier disease, as active disease and less irreversible functional deficit.
format Online
Article
Text
id pubmed-3123457
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-31234572011-07-14 Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis Chung, Ho Yin Lau, Chak Sing Wu, Ka Pik Wong, Woon Sing MOK, Mo Yin Clin Rheumatol Original Article Early diagnosis of spondyloarthritis (SpA) is essential as anti-tumor necrosis factor therapy can achieve significant symptomatic relief and control of disease activity. This study aims to compare the clinical characteristics, disease activity, and functional status of a Chinese cohort of SpA patients who were re-classified into ankylosing spondylitis (AS) patients fulfilling the modified New York (MNY) criteria, those with undifferentiated SpA (USpA) fulfilling the European Spondyloarthropathy Study Group (ESSG) classification criteria only (USpA/ESSG) and those who fulfill Assessment of SpondyloArthritis International Society (ASAS) only (USpA/ASAS). Disease activity was evaluated by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), severity of morning stiffness, patient global assessment, and C-reactive protein. Functional status was evaluated by Bath Ankylosing Spondylitis Functional Index (BASFI), modified Schober index, and dimension of chest expansion. One hundred and twenty-eight patients with disease duration of 16.3 ± 10.4 years were recruited. Patients in USpA/ESSG and USpA/ASAS were significantly younger (p = 0.01), had shorter disease duration (p < 0.01), and lower BASFI (p = 0.03) than established AS patients. All three groups have active disease with comparable BASDAI >3. BASFI correlated inversely with dimension of chest expansion and negatively modified Schober index in AS patients (p < 0.01) and modestly with BASDAI (r = 0.25, p < 0.01). BASFI correlated moderately with BASDAI in USpA/ESSG (r = 0.61, p < 0.01) but not with chest expansion or modified Schober index. Compared with established AS patients recognized by MNY criteria, patients fulfilling USpA defined by ESSG or ASAS criteria had earlier disease, as active disease and less irreversible functional deficit. Springer-Verlag 2011-02-19 2011 /pmc/articles/PMC3123457/ /pubmed/21336823 http://dx.doi.org/10.1007/s10067-011-1693-6 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Chung, Ho Yin
Lau, Chak Sing
Wu, Ka Pik
Wong, Woon Sing
MOK, Mo Yin
Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis
title Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis
title_full Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis
title_fullStr Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis
title_full_unstemmed Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis
title_short Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis
title_sort comparison of performance of the assessment of spondyloarthritis international society, the european spondyloarthropathy study group and the modified new york criteria in a cohort of chinese patients with spondyloarthritis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123457/
https://www.ncbi.nlm.nih.gov/pubmed/21336823
http://dx.doi.org/10.1007/s10067-011-1693-6
work_keys_str_mv AT chunghoyin comparisonofperformanceoftheassessmentofspondyloarthritisinternationalsocietytheeuropeanspondyloarthropathystudygroupandthemodifiednewyorkcriteriainacohortofchinesepatientswithspondyloarthritis
AT lauchaksing comparisonofperformanceoftheassessmentofspondyloarthritisinternationalsocietytheeuropeanspondyloarthropathystudygroupandthemodifiednewyorkcriteriainacohortofchinesepatientswithspondyloarthritis
AT wukapik comparisonofperformanceoftheassessmentofspondyloarthritisinternationalsocietytheeuropeanspondyloarthropathystudygroupandthemodifiednewyorkcriteriainacohortofchinesepatientswithspondyloarthritis
AT wongwoonsing comparisonofperformanceoftheassessmentofspondyloarthritisinternationalsocietytheeuropeanspondyloarthropathystudygroupandthemodifiednewyorkcriteriainacohortofchinesepatientswithspondyloarthritis
AT mokmoyin comparisonofperformanceoftheassessmentofspondyloarthritisinternationalsocietytheeuropeanspondyloarthropathystudygroupandthemodifiednewyorkcriteriainacohortofchinesepatientswithspondyloarthritis